GSA Capital Partners’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-137,408
Closed -$121K 1994
2022
Q3
$121K Sell
137,408
-234,511
-63% -$284K 0.02% 1335
2022
Q2
$417K Sell
371,919
-109,384
-23% -$93.9K 0.06% 608
2022
Q1
$669K Buy
481,303
+395,576
+461% +$846K 0.09% 366
2021
Q4
$292K Buy
+85,727
New +$483K 0.04% 953

Other funds holding AFIB

GSA Capital Partners's AFIB Position: Q4 2022 in Review

GSA Capital Partners sold out of Acutus Medical Inc (AFIB) in Q4 2022, closing a stake of 137,408 shares — an estimated $121K sold.

GSA Capital Partners first reported a position in AFIB in Q4 2021 and held it in 4 quarters. The position peaked at $669K in Q1 2022. 38 funds tracked by Wall St. Rank hold AFIB as of Q4 2022.

  • GSA Capital Partners reported no remaining Acutus Medical Inc position as of Q4 2022 after selling out during the quarter.
  • GSA Capital Partners sold 137,408 Acutus Medical Inc shares in Q4 2022, an estimated $121K.
  • GSA Capital Partners first reported a position in Acutus Medical Inc in Q4 2021 and held it in 4 quarters.
  • GSA Capital Partners's Acutus Medical Inc position peaked at $669K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.